Stock listing
Aquis:ABNXP ABIONYX Pharma SA Share Price
UK listing (Aquis) of ABIONYX Pharma SA · home listing Euronext:ABNX
Follow ABIONYX Pharma SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:ABNX
€1.63 EUR +0.06 (+3.8%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ABNX
- Day range
- €1.55 – €1.63 EUROct 20, 2026
- Volume
- 72,053 sharesOct 20, 2026
- Market cap
- €71.40M EURAt the close on Oct 20, 2026 · price × 43.81M shares outstanding
- 52-week range
- €1.41 – €5.21 EURLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ABNX · Home | €1.63 EUR | +0.06 (+3.8%) | 72,053 | €1.588 | €1.63 | €1.55 | €1.57 | Close on Oct 20, 2026 |
| LSE:0RAG | €1.584 EUR | +0.114 (+7.8%) | 4 | €1.56 | €1.584 | €1.56 | €1.47 | Close on Oct 20, 2026 |
| Frankfurt:609 | €1.498 EUR | +0.02 (+1.4%) | — | €1.498 | €1.498 | €1.498 | €1.478 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · EURONEXT:ABNX · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €1.63 | +0.06 | +3.8% | €1.588 | €1.63 | €1.55 | 72,053 | |
| €1.57 | +0.024 | +1.6% | €1.56 | €1.59 | €1.522 | 110,040 | |
| €1.546 | +0.062 | +4.2% | €1.484 | €1.568 | €1.48 | 75,888 | |
| €1.484 | +0.042 | +2.9% | €1.46 | €1.498 | €1.442 | 61,272 | |
| €1.442 | +0.01 | +0.7% | €1.45 | €1.468 | €1.414 | 80,695 | |
| €1.432 | -0.088 | -5.8% | €1.53 | €1.53 | €1.422 | 141,061 | |
| €1.52 | -0.02 | -1.3% | €1.52 | €1.528 | €1.50 | 112,773 | |
| €1.54 | +0.064 | +4.3% | €1.49 | €1.54 | €1.454 | 118,552 | |
| €1.476 | -0.062 | -4.0% | €1.56 | €1.574 | €1.476 | 159,127 | |
| €1.538 | -0.018 | -1.2% | €1.64 | €1.65 | €1.512 | 246,812 | |
| €1.556 | -0.048 | -3.0% | €1.594 | €1.62 | €1.556 | 151,784 | |
| €1.604 | -0.018 | -1.1% | €1.64 | €1.70 | €1.604 | 165,453 | |
| €1.622 | -0.086 | -5.0% | €1.66 | €1.67 | €1.614 | 225,742 | |
| €1.708 | -0.052 | -3.0% | €1.788 | €1.788 | €1.702 | 53,156 | |
| €1.76 | +0.002 | +0.1% | €1.756 | €1.792 | €1.744 | 43,306 | |
| €1.758 | -0.024 | -1.3% | €1.77 | €1.80 | €1.752 | 39,117 | |
| €1.782 | +0.002 | +0.1% | €1.77 | €1.804 | €1.75 | 45,766 | |
| €1.78 | +0.006 | +0.3% | €1.774 | €1.81 | €1.73 | 117,743 | |
| €1.774 | -0.076 | -4.1% | €1.762 | €1.836 | €1.74 | 186,478 | |
| €1.85 | -0.07 | -3.6% | €1.90 | €1.94 | €1.85 | 138,147 | |
| €1.92 | +0.054 | +2.9% | €1.864 | €1.92 | €1.826 | 116,090 | |
| €1.866 | +0.04 | +2.2% | €1.864 | €1.866 | €1.78 | 167,797 | |
| €1.826 | -0.08 | -4.2% | €1.908 | €1.926 | €1.812 | 166,640 | |
| €1.906 | +0.204 | +12.0% | €1.75 | €1.924 | €1.74 | 408,781 | |
| €1.702 | +0.032 | +1.9% | €1.674 | €1.76 | €1.664 | 215,521 | |
| €1.67 | -0.02 | -1.2% | €1.69 | €1.698 | €1.66 | 114,069 | |
| €1.69 | -0.15 | -8.2% | €1.82 | €1.822 | €1.666 | 324,991 | |
| €1.84 | +0.032 | +1.8% | €1.866 | €1.92 | €1.81 | 251,370 | |
| €1.808 | -0.092 | -4.8% | €1.90 | €1.93 | €1.808 | 189,436 | |
| €1.90 | +0.056 | +3.0% | €1.90 | €1.946 | €1.882 | 151,314 | |
| €1.844 | -0.016 | -0.9% | €1.872 | €1.884 | €1.83 | 215,433 | |
| €1.86 | -0.04 | -2.1% | €1.92 | €1.92 | €1.86 | 170,390 | |
| €1.90 | -0.002 | -0.1% | €1.904 | €1.93 | €1.882 | 76,161 | |
| €1.902 | -0.036 | -1.9% | €1.94 | €1.98 | €1.902 | 100,778 | |
| €1.938 | -0.028 | -1.4% | €1.95 | €1.974 | €1.93 | 102,627 | |
| €1.966 | -0.039 | -1.9% | €2.01 | €2.02 | €1.95 | 147,813 | |
| €2.005 | -0.025 | -1.2% | €2.02 | €2.06 | €1.994 | 122,781 | |
| €2.03 | +0.03 | +1.5% | €2.03 | €2.32 | €2.01 | 785,652 | |
| €2.00 | +0.002 | +0.1% | €1.97 | €2.02 | €1.97 | 57,316 | |
| €1.998 | +0.024 | +1.2% | €1.974 | €2.01 | €1.962 | 123,303 | |
| €1.974 | +0.034 | +1.8% | €1.944 | €1.984 | €1.944 | 54,588 | |
| €1.94 | -0.014 | -0.7% | €1.954 | €1.956 | €1.92 | 93,417 | |
| €1.954 | -0.038 | -1.9% | €1.992 | €1.992 | €1.93 | 105,567 | |
| €1.992 | +0.062 | +3.2% | €1.95 | €2.035 | €1.944 | 181,405 | |
| €1.93 | -0.048 | -2.4% | €1.988 | €1.988 | €1.904 | 222,531 | |
| €1.978 | -0.016 | -0.8% | €1.996 | €2.025 | €1.95 | 162,544 | |
| €1.994 | -0.006 | -0.3% | €1.984 | €2.015 | €1.96 | 184,472 | |
| €2.00 | +0.044 | +2.2% | €1.952 | €2.01 | €1.932 | 228,847 | |
| €1.956 | -0.054 | -2.7% | €2.025 | €2.08 | €1.95 | 159,536 | |
| €2.01 | +0.108 | +5.7% | €1.91 | €2.05 | €1.894 | 319,455 | |
| €1.902 | -0.018 | -0.9% | €1.936 | €1.938 | €1.882 | 105,807 | |
| €1.92 | -0.048 | -2.4% | €1.97 | €1.984 | €1.91 | 146,824 | |
| €1.968 | +0.08 | +4.2% | €1.90 | €2.00 | €1.87 | 161,271 | |
| €1.888 | -0.032 | -1.7% | €1.86 | €1.956 | €1.86 | 103,379 | |
| €1.92 | +0.014 | +0.7% | €1.948 | €1.96 | €1.88 | 106,959 | |
| €1.906 | +0.036 | +1.9% | €1.886 | €1.92 | €1.85 | 69,901 | |
| €1.87 | +0.014 | +0.8% | €1.88 | €1.898 | €1.87 | 37,981 | |
| €1.856 | -0.05 | -2.6% | €1.91 | €1.944 | €1.83 | 105,574 | |
| €1.906 | +0.04 | +2.1% | €1.87 | €1.906 | €1.84 | 66,255 | |
| €1.866 | -0.05 | -2.6% | €1.94 | €1.95 | €1.85 | 122,731 | |
| €1.916 | -0.042 | -2.1% | €1.96 | €1.96 | €1.87 | 83,164 | |
| €1.958 | +0.012 | +0.6% | €1.96 | €2.025 | €1.958 | 109,383 | |
| €1.946 | -0.064 | -3.2% | €1.99 | €2.01 | €1.914 | 125,890 | |
| €2.01 | +0.09 | +4.7% | €1.926 | €2.11 | €1.90 | 305,651 | |
| €1.92 | +0.056 | +3.0% | €1.862 | €1.966 | €1.86 | 181,983 | |
| €1.864 | +0.022 | +1.2% | €1.846 | €1.868 | €1.82 | 55,926 | |
| €1.842 | -0.044 | -2.3% | €1.898 | €1.898 | €1.842 | 59,750 |
- Ticker
- Aquis:ABNXP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Aquis
- Currency
- EUR
What changed lately
Latest news release · Oct 7, 2026
ABIONYX Pharma and OLON Enter Into Strategic Manufacturing Partnership to Prepare CER-001 Biologic for Regulatory Approval and Commercial Supply
Latest deck · March 2026
Investor Presentation (March 2026)
Investor deck · 16 slides
Latest news
ABIONYX Pharma and OLON Enter Into Strategic Manufacturing Partnership to Prepare CER-001 Biologic for Regulatory Approval and Commercial Supply
Oct 7, 2026
Closed €1.54 (-1.2%) on Oct 7, 2026
ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Oct 2, 2026
Closed €1.60 (-1.1%) on Oct 5, 2026
Information relative au nombre total de droits de vote et d’actions composant le capital social
Oct 2, 2026
Closed €1.62 (-5.0%) on Oct 2, 2026
ABIONYX Pharma Announces the Settlement of an Anticipated Amortization Payment in Accordance With the Terms of Its Bonds Financing Agreement
Oct 2, 2026
Closed €1.62 (-5.0%) on Oct 2, 2026
ABIONYX Pharma annonce le règlement d’un amortissement anticipé conformément aux termes de son contrat de Financement Obligataire
Oct 2, 2026
Closed €1.62 (-5.0%) on Oct 2, 2026
ABIONYX Pharma: Half Year Results 2026
Sep 23, 2026
Closed €1.77 (-4.1%) on Sep 24, 2026
ABIONYX Pharma Reaches Another Key Milestone in the Industrialization of CER-001 by Entering into a Strategic Partnership with TEXCELL (ABL Diagnostics) for the Viral Safety and Clearance of Biologics
Sep 10, 2026
Closed €1.84 (+1.8%) on Sep 11, 2026
ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the First Half of 2026
Aug 27, 2026
Closed €2.03 (+1.5%) on Aug 28, 2026
ABIONYX Pharma: Half-Year Review of the Liquidity Agreement Entered into with TP ICAP (Europe) SA
Jul 6, 2026
Closed €1.93 (-5.2%) on Jul 7, 2026
Decks
Investor Presentation (March 2026)
Investor deck · 16 slides · March 2026
Investor Presentation (March 2026)
Investor deck · 16 slides · March 2026
Investor Presentation (February 2026)
Investor deck · 16 slides · February 2026
Shareholder Meeting (June 2022)
Shareholder meeting · 29 slides · Jun 28, 2022
ABIONYX Pharma SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 32 in the last 12 months · 37 in all · newest Oct 7, 2026 · oldest 2025
- Decks
- 5 decks · latest March 2026
Where ABIONYX Pharma SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ABNX · Home listing | Euronext | France | EUR |
| LS Exchange:A14QR9 | LS Exchange | Germany | EUR |
| gettex:609 | gettex | Germany | EUR |
| LSE:0RAG | LSE | United Kingdom | EUR |
| Lang & Schwarz:A14QR9 | Lang & Schwarz | Germany | EUR |
| Aquis:ABNXP · This page | Aquis | United Kingdom | EUR |
| Aquis:ABNXP | Aquis | United Kingdom | EUR |
| Turquoise:ABNXP | Turquoise | United Kingdom | EUR |
| Dusseldorf:609 | Dusseldorf | Germany | EUR |
| Frankfurt:609 | Frankfurt | Germany | EUR |
| Hamburg:609 | Hamburg | Germany | EUR |
| Munich:609 | Munich | Germany | EUR |
| Stuttgart:609 | Stuttgart | Germany | EUR |
| Tradegate:609 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about ABIONYX Pharma SA.